How much money does Nephros make? Nephros has a market capitalization of $51.17 million and generates $8.56 million in revenue each year. The company earns $-4.77 million in net income (profit) each year or ($0.38) on an earnings per share basis.
Employees: 27
Email: [email protected]
Phone: 020-1343-5202
Show more
See More
Jan 14, 2022 . (NASDAQ: NEPH) Nephros currently has 10,233,083 outstanding shares. With Nephros stock trading at $5.25 per share, the total value of Nephros stock (market capitalization) is $78.28M . Nephros stock was originally listed at a price of $7.05 in Aug 15, 2019 .
Show more
See More
Nephros (NASDAQ:NEPH) has a recorded net income of -$4.77 million. NEPH has generated -$0.38 earnings per share over the last four quarters. What is Nephros's EPS forecast for next year? Nephros's earnings are expected to grow from ($0.40) per share to ($0.11) per share in the next year.
Email: [email protected]
Phone: (844) 978-6257
Show more
See More
Jan 05, 2022 . Insiders have purchased a total of 13,950 Nephros shares in the last 24 months for a total of $106,620.00 bought. This page was last updated on 1/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring
Email: [email protected]
Phone: (844) 978-6257
Show more
See More
Jan 11, 2022 . Net revenue for 2021 is expected to be $10.4 million, the highest in the company’s history and a 21% increase over 2020. Net revenue for the quarter ended December 31, 2021 is expected to be $2 ...
Show more
See More
Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist ...
Show more
See More
What is Nephros worth? According to my valuation model, the stock is currently overvalued by about 22%, trading at US$8.37 compared to my intrinsic value of $6.88.
Show more
See More
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 12% of Nephros...
Show more
See More
Jan 11, 2022 . DKODING. 11/01/2022 07:00 PM. Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an 18% Year-Over-Year Increase; Provides 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue. SOUTH ORANGE, NJ, Jan. 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire …
Show more
See More
In fact, the recent purchase by Sandra Pessin was the biggest purchase of Nephros shares made by an insider individual in the last twelve months, according to our records. That means that an...
Show more
See More
Jan 13, 2022 . SOUTH ORANGE, NJ, Jan. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today issued a 2022 letter to shareholders. Dear Shareholder, We are entering 2022 from our strongest position ever. …
See More
In fact, the recent purchase by Sandra Pessin was the biggest purchase of Nephros shares made by an insider individual in the last twelve months, according to our records. That means that an...
Show more
See More
Nephros, Inc. (NASDAQ:NEPH) Q4 2020 Earnings Conference Call November 4 2021 4:30 PM ET Company Participants Andy Astor - President & Chief Executive Officer Kirin Smith - …
Show more
See More
The Nephros S100 Filters are disposable point of use micro-filters used to filter EPA quality drinking water. The filters retain bacteria. By retaining bacteria in water for washing and drinking, the filters may aid in infection control. These highly effective filters are ideal for high-risk patient areas: ICU/NICU, Transplant, Oncology ...
Show more
See More
The mammalian nephron is a long tube-like structure, its length varying from 35–55 mm long. At one end, the tube is closed, folded and expanded, into a double-walled, a cuplike structure called the Bowman’s capsule or renal corpuscular capsule, which encloses a cluster of microscopic blood vessels called the glomerulus.
Show more
See More
Nephros does not undertake any responsibility to update the forward-looking statements in this release.Investor Relations Contact:Kirin Smith, PresidentPCG Advisory, Inc.(646) 863-6519ksmith ...
Show more
See More
Gematria value of Nephros is 333 - English, Hebrew and Simple Gematria Calculator Values.
Show more
See More
Nephros reported net revenues in the fourth quarter of $2.3 million, a 10% increase over third quarter of 2020, and a 26% decrease versus fourth quarter of 2019. For the full year, net revenues...
Show more
See More
The company will announce its fourth quarter and fiscal 2021 results on Wednesday, February 23, 2022, after market close and host a conference call that same day at 4:30 PM ET. Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology.
Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets.
What is Nephron? A nephron is the basic structural and functional unit of the kidney. They are the microscopic structure composed of a renal corpuscle and a renal tubule. The word nephron is derived from the Greek word – Nephros, meaning kidney.
There are about millions of nephrons in each human kidney. The mammalian nephron is a long tube-like structure, its length varying from 35–55 mm long.